Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-003250
Filing Date
2025-08-14
Accepted
2025-08-14 08:04:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9208
  Complete submission text file 0001172661-25-003250.txt   10987
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91349 | Film No.: 251214471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 16 PALACE STREET LONDON X0 SW1E 5JD
Business Address 16 PALACE STREET LONDON X0 SW1E 5JD 02072272700
Polar Capital Holdings Plc (Filed by) CIK: 0001837309 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A